Enbrel(Etanercept)
AMGN
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Amgen Inc.
$632.3M
Medicare cost, 2024
$632.3M
Medicare cost, 2024
Medicare drug plans spent $632.3 million on Enbrel (etanercept) in 2024, for 80,775 prescriptions and refills filled by 10,535 patients. It ranks 82nd among all drugs by Medicare drug plan spending. At about $7,828 per prescription it is a high-cost drug. California accounts for the most spending ($66.8 million, 11% of the total).
Medicare cost, 2024
$632.3M
+0.9% from 2023
Prescriptions
81K
$7,827.79 per claim
Patients
11K
7,008 prescribers
Total spending, 2024
$632.8M
$60,025.75 per patient
Questions and answers
How much does Medicare spend on Enbrel?
Medicare prescription drug plans paid $632.3M for Enbrel in 2024, for 80,775 prescriptions and refills to 10,535 patients (up 0.9% from 2023). The average cost per claim was $7,827.79.
Which state spends the most on Enbrel?
California had the highest Medicare cost for Enbrel in 2024: $66.8M for 10,024 claims, followed by New York ($46.6M).
Who prescribes Enbrel the most?
Michael Babilonia Roman, internal medicine in Mayaguez, PR, had the highest Medicare cost for Enbrel in 2024: 340 claims costing $2.5M.
Who makes Enbrel?
Enbrel is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Amgen.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Enbrel was $632.8M in 2024, the highest year shown.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Enbrel, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Michael Babilonia Roman Mayaguez, PR | Internal Medicine | 340 | 30 | $2.5M |
| Elvin R Garcia McAllen, TX | Rheumatology | 195 | 23 | $1.6M |
| Jolanta Sobotka-Czarnecki Flint, MI | Rheumatology | 199 | 21 | $1.5M |
| Richard B Gremillion Millcreek, UT | Rheumatology | 171 | 18 | $1.4M |
| Kenneth B Wiesner Sacramento, CA | Rheumatology | 149 | 18 | $1.2M |
| John Vischio Glastonbury, CT | Internal Medicine | 116 | 13 | $1.0M |
| James E Dowd Brighton, MI | Rheumatology | 121 | 14 | $992K |
| William W Mullins North Bethesda, MD | Rheumatology | 64 | 11 | $976K |
| Roberto D Alvarez Aibonito, PR | Rheumatology | 126 | 21 | $937K |
| Grace A Makhlouf Sugar Land, TX | Rheumatology | 110 | 13 | $893K |
| Steven A Portney Bingham Farms, MI | Rheumatology | 117 | 12 | $853K |
| Don L Stromquist Murray, UT | Rheumatology | 94 | 12 | $824K |
| James E Gore Nashville, TN | Rheumatology | 113 | 12 | $815K |
| Victoria Katz Brooklyn, NY | Rheumatology | 110 | 28 | $783K |
| David A Campbell Fort Wayne, IN | Rheumatology | 96 | Under 11 | $780K |
| Linda M Atkinson Baldwin Park, CA | Internal Medicine | 157 | 21 | $765K |
| Juan M Rodriguez Bayamon, PR | Rheumatology | 93 | 12 | $688K |
| Khalid M Syed Lynn, MA | Rheumatology | 80 | 12 | $687K |
| 1790785160 | Rheumatology | 89 | Under 11 | $673K |
| Sohrab Fallahi Montgomery, AL | Rheumatology | 87 | 13 | $670K |
| Leroy A Pacheco Albuquerque, NM | Rheumatology | 72 | Under 11 | $668K |
| Monika Mohan Okemos, MI | Rheumatology | 90 | 15 | $657K |
| Robert W Shurmur Battle Creek, MI | Rheumatology | 79 | Under 11 | $646K |
| Brian J Keroack Portland, ME | Rheumatology | 82 | 11 | $645K |
| Gwendolyn Kane-Wanger Waban, MA | Internal Medicine | 76 | Under 11 | $629K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7,214 | 85,248 | 11,304 | $611.6M |
| 2023 | 7,033 | 81,917 | 10,670 | $626.9M |
| 2024 | 7,008 | 80,775 | 10,535 | $632.3M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Amgen | 80,845 | $632.8M |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 14
- RxNorm concept IDs
- 1653223, 1653225, 2182338, 2182340, 2392140
- Application numbers
- BLA103795
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 597,170 side-effect reports named etanercept, the active ingredient of Enbrel (reports from 2004 on). 216,192 of them (36.2%) were serious, 17,506 named a death and 66,994 named a hospital stay. The reactions named most often were drug ineffective, injection site pain and rheumatoid arthritis. 55,894 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
597,170
7,857 in 2025 (-34.1% from 2024)
Serious
36.2%
216,192 reports
Deaths named
17,506
2.9% of reports
Hospital stays
66,994
11.2% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Enbrel?
597,170 reports from 2004 through September 2026 named etanercept, the active ingredient of Enbrel. 216,192 of them (36.2%) were serious, 17,506 named a death and 66,994 named a hospital stay.
What are the most reported side effects of Enbrel?
75,666 reports named drug ineffective, the reaction named most often, followed by injection site pain (56,858) and rheumatoid arthritis (47,139). In the last 5 years the reaction named most often was drug ineffective (10,000 reports). A report can name several reactions.
How many side-effect reports named Enbrel in 2025?
7,857 reports were received in 2025 (-34.1% from 2024). 2026 so far: 5,446 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Enbrel caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Enbrel caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with etanercept: Enbrel Sureclick, Enbrel Mini
- Makers on the stock market:
AMGN·AMGN drug pipeline - Drug approvals (1 approval on file for etanercept) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (etanercept) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.